This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Lewis L. Judd, MD; David S. Janowsky, MD; David S. Segal, PhD; Leighton Y. Huey, MD

Arch Gen Psychiatry. 1980;37(5):583-586.

Abstract
• Intravenous naloxone hydrochloride (20 mg) was administered to eight normal control subjects and 12 affective disorder patients manifesting manic or hypomanic symptoms. On two consecutive days, in a counterbalanced order, naloxone and placebo were given in a double-blind crossover design. The overall effect of naloxone was to decrease pulse rate and to promote lethargy and inactivation. The normal controls manifested reduced feelings of well-being, and the manic patients noted a subjective sense of slowing. There was a variable response pattern to naloxone in the manic patients in which four of the 12 patients manifested an observable reduction in their manic symptoms and behavior after the naloxone administration. Naloxone seems to have had a nonspecific subduing effect in both normal subjects and patients and may also have had a selectively greater effect in a small subsample of the manics.

Author Affiliations
From the Department of Psychiatry, School of Medicine, the University of California at San Diego (Drs Judd, Janowsky, Segal, and Huey), and the Psychiatry Service, San Diego Veterans Administration Medical Center (Drs Judd, Janowsky, and Huey), La Jolla, Calif.

Footnotes
Accepted for publication June 29, 1979.

Reprint requests to Department of Psychiatry, M-003, School of Medicine, University of California at San Diego, La Jolla, CA 92093 (Dr Judd).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

High-Dose Naloxone Infusions in Normals: Dose-Dependent Behavioral, Hormonal, and Physiological Responses
Cohen et al.
Arch Gen Psychiatry 1983;40:613-619.
ABSTRACT  

Neurotransmitters in Anxiety
Hoehn-Saric
Arch Gen Psychiatry 1982;39:735-742.
ABSTRACT  

Short-term Naloxone Administration in Schizophrenic and Manic Patients: A World Health Organization Collaborative Study
Pickar et al.
Arch Gen Psychiatry 1982;39:313-319.
ABSTRACT